This summer we accepted only 5 high school interns to participate in our Biomedical Research Internship. They are about half way through their training and have had the opportunity to do things like: store and retrieve samples for the biorepository, … Continue reading →
Researchers at UC San Diego are developing a new drug to treat CLL. The drug, cirmutuzumab, is an antibody designed to attach to a protein on the surface of CLL cells. Researchers hope that this process will block cancerous cell growth and survival. Right now, cirmtuzumab is being tested for its safety and effectiveness in humans in a Phase One clinical trial. “A brand new way to target and kill blood cancer,” WNDU, features Thomas Kipps, MD, PhD.
(Source: http://www.utsandiego.com/news/2014/sep/17/ucsd-leukemia-cll-trial-kipps-cirm/, https://clinicaltrials.gov/ct2/show/NCT02222688?term=cirmtuzumab&rank=1 )
Have you seen the new Jacob’s Medical Center building being built just across from the Moores Cancer Center? To read more about the project and the incredible commitment to creating a healthier world, CLICK HERE!
The $839 million facility is part of a multi-billion dollar university investment in the future of health care for the entire region. It will allow UC San Diego Health System to fulfill its potential of becoming one of the country’s premier academic health systems.
The Leukemia & Lymphoma Society has awarded Thomas J. Kipps, MD, PhD, Distinguished Professor of Medicine at the University of California, San Diego School of Medicine, with a 5-year, $6.25 million Specialized Center of Research program grant to support research on chronic lymphocytic leukemia (CLL), the most common adult leukemia in the United States. Read More…
Stopping cancer’s spread: New protein found to control deadly cancer metastasis
Researchers have found a critical element that may explain why some cancers spread farther and faster than others, a discovery that could lead to one of the Holy Grails of cancer treatment: containing the disease.
Scientists from the University of California, San Diego School of Medicine, Dr. Thomas J. Kipps and colleagues, have identified a protein that seems to serve as a switch, regulating the spread of cancer from the primary tumor to distant spots in the body – a process known as metastasis. The protein is used by embryo cells during early development, but then disappears from the body after an individual comes out of the womb.
CLL Patient Meeting from 6/5/2013. Dr. Laura Rassenti, Director of the CLL Research Consortium (CRC) Biorepository. She gives an overview of the biology and genetics of CLL. Highlights: Latest Research, Prognostics, VH, lab studies…
With My Answer To Cancer, we already have some of the top scientists and doctors in the nation committed to the fight against cancer. Now, we need you. This initiative has the power to transform cancer care, but it won’t happen without your support.